It's a game changer in terms of diabetic management’: A qualitative study of adolescents' and parents' experiences of a 6-month trial of continuous glucose monitoring in type 2 diabetes
Maheesha Fernando, Alexia S. Peña, Ashlee King, Melissa Oxlad
{"title":"It's a game changer in terms of diabetic management’: A qualitative study of adolescents' and parents' experiences of a 6-month trial of continuous glucose monitoring in type 2 diabetes","authors":"Maheesha Fernando, Alexia S. Peña, Ashlee King, Melissa Oxlad","doi":"10.1111/dme.70430","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Aim</h3>\n \n <p>To qualitatively explore adolescents with type 2 diabetes (T2D) using any treatment regimen and parents of such adolescents' experiences of a 6-month trial of continuous glucose monitoring (CGM) and its perceived barriers and facilitators.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Adolescents provided with CGM sensors (Freestyle Libre 2) free of charge for 6 months and parents recruited from the outpatient paediatric diabetes clinic at the Women's and Children's Hospital, South Australia participated. Four adolescents and six parents participated in a separate focus group or a semi-structured interview within 1 month (baseline) of CGM use; three adolescents and four parents participated in a focus group after 6 months of CGM use. Data were analysed using reflexive thematic analysis.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>We generated four themes: (1) A Convenient and Practical Tool for Adolescent Monitoring, Self-Management, Education, and Behaviour Change; (2) Enhanced Parental Diabetes Oversight and Reduced Family Emotional Burden; (3) Psychosocial, Practical, and Affordability Barriers to Adolescent CGM Use; (4) Education, Improved Adhesion, and Supportive School Environments as Facilitators of Adolescent CGM Use.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Adolescents with T2D and parents perceived CGM as a more acceptable and convenient tool than finger prick blood glucose monitoring. CGM benefits included facilitating education, improving self-management skills, and promoting behavioural modification. CGM was also perceived to reduce families' emotional burden associated with diabetes management. Device limitations, including technology accuracy, alarms, and adhesion issues, posed challenges for families. Equitable access and funding models were the main barriers to the wider adoption of CGM in this population within Australia.</p>\n </section>\n </div>","PeriodicalId":11251,"journal":{"name":"Diabetic Medicine","volume":"43 11","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dme.70430","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetic Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/dme.70430","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/22 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Aim
To qualitatively explore adolescents with type 2 diabetes (T2D) using any treatment regimen and parents of such adolescents' experiences of a 6-month trial of continuous glucose monitoring (CGM) and its perceived barriers and facilitators.
Methods
Adolescents provided with CGM sensors (Freestyle Libre 2) free of charge for 6 months and parents recruited from the outpatient paediatric diabetes clinic at the Women's and Children's Hospital, South Australia participated. Four adolescents and six parents participated in a separate focus group or a semi-structured interview within 1 month (baseline) of CGM use; three adolescents and four parents participated in a focus group after 6 months of CGM use. Data were analysed using reflexive thematic analysis.
Results
We generated four themes: (1) A Convenient and Practical Tool for Adolescent Monitoring, Self-Management, Education, and Behaviour Change; (2) Enhanced Parental Diabetes Oversight and Reduced Family Emotional Burden; (3) Psychosocial, Practical, and Affordability Barriers to Adolescent CGM Use; (4) Education, Improved Adhesion, and Supportive School Environments as Facilitators of Adolescent CGM Use.
Conclusions
Adolescents with T2D and parents perceived CGM as a more acceptable and convenient tool than finger prick blood glucose monitoring. CGM benefits included facilitating education, improving self-management skills, and promoting behavioural modification. CGM was also perceived to reduce families' emotional burden associated with diabetes management. Device limitations, including technology accuracy, alarms, and adhesion issues, posed challenges for families. Equitable access and funding models were the main barriers to the wider adoption of CGM in this population within Australia.
期刊介绍:
Diabetic Medicine, the official journal of Diabetes UK, is published monthly simultaneously, in print and online editions.
The journal publishes a range of key information on all clinical aspects of diabetes mellitus, ranging from human genetic studies through clinical physiology and trials to diabetes epidemiology. We do not publish original animal or cell culture studies unless they are part of a study of clinical diabetes involving humans. Categories of publication include research articles, reviews, editorials, commentaries, and correspondence. All material is peer-reviewed.
We aim to disseminate knowledge about diabetes research with the goal of improving the management of people with diabetes. The journal therefore seeks to provide a forum for the exchange of ideas between clinicians and researchers worldwide. Topics covered are of importance to all healthcare professionals working with people with diabetes, whether in primary care or specialist services.
Surplus generated from the sale of Diabetic Medicine is used by Diabetes UK to know diabetes better and fight diabetes more effectively on behalf of all people affected by and at risk of diabetes as well as their families and carers.”